Status: current, Defined. Date: 30-Nov 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3173751000168111 | Lyxumia Treatment Initiation Pack (lixisenatide 10 microgram / 0.2 mL) injection [1 x 3 mL pen device] (&) (lixisenatide 20 microgram / 0.2 mL) injection [1 x 3 mL pen device], 1 pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3173761000168113 | Lyxumia Treatment Initiation Pack (1 x 10 microgram/0.2 mL (3 mL) pen device, 1 x 20 microgram/0.2 mL (3 mL) pen device), 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lyxumia Treatment Initiation Pack (lixisenatide 10 microgram / 0.2 mL) injection [1 x 3 mL pen device] (&) (lixisenatide 20 microgram / 0.2 mL) injection [1 x 3 mL pen device], 1 pack (containered trade product pack) | Is a | Lyxumia Treatment Initiation Pack (1 x 10 microgram/0.2 mL (3 mL) pen device, 1 x 20 microgram/0.2 mL (3 mL) pen device), 1 pack | true | Inferred relationship | Some | ||
| Lyxumia Treatment Initiation Pack (lixisenatide 10 microgram / 0.2 mL) injection [1 x 3 mL pen device] (&) (lixisenatide 20 microgram / 0.2 mL) injection [1 x 3 mL pen device], 1 pack (containered trade product pack) | Is a | containered trade product pack | false | Inferred relationship | Some | ||
| Lyxumia Treatment Initiation Pack (lixisenatide 10 microgram / 0.2 mL) injection [1 x 3 mL pen device] (&) (lixisenatide 20 microgram / 0.2 mL) injection [1 x 3 mL pen device], 1 pack (containered trade product pack) | has TPUU | Lyxumia 10 microgram/0.2 mL injection, 3 mL pen device | true | Inferred relationship | Some | 2 | |
| Lyxumia Treatment Initiation Pack (lixisenatide 10 microgram / 0.2 mL) injection [1 x 3 mL pen device] (&) (lixisenatide 20 microgram / 0.2 mL) injection [1 x 3 mL pen device], 1 pack (containered trade product pack) | has TPUU | Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device | true | Inferred relationship | Some | 1 | |
| Lyxumia Treatment Initiation Pack (lixisenatide 10 microgram / 0.2 mL) injection [1 x 3 mL pen device] (&) (lixisenatide 20 microgram / 0.2 mL) injection [1 x 3 mL pen device], 1 pack (containered trade product pack) | has container type | pack | true | Inferred relationship | Some | ||
| Lyxumia Treatment Initiation Pack (lixisenatide 10 microgram / 0.2 mL) injection [1 x 3 mL pen device] (&) (lixisenatide 20 microgram / 0.2 mL) injection [1 x 3 mL pen device], 1 pack (containered trade product pack) | has component pack | Lyxumia 10 microgram/0.2 mL injection, 3 mL pen device | true | Inferred relationship | Some | ||
| Lyxumia Treatment Initiation Pack (lixisenatide 10 microgram / 0.2 mL) injection [1 x 3 mL pen device] (&) (lixisenatide 20 microgram / 0.2 mL) injection [1 x 3 mL pen device], 1 pack (containered trade product pack) | has component pack | Lyxumia 20 microgram/0.2 mL injection, 3 mL pen device | true | Inferred relationship | Some | ||
| Lyxumia Treatment Initiation Pack (lixisenatide 10 microgram / 0.2 mL) injection [1 x 3 mL pen device] (&) (lixisenatide 20 microgram / 0.2 mL) injection [1 x 3 mL pen device], 1 pack (containered trade product pack) | has TP | Lyxumia Treatment Initiation Pack | true | Inferred relationship | Some | ||
| Lyxumia Treatment Initiation Pack (lixisenatide 10 microgram / 0.2 mL) injection [1 x 3 mL pen device] (&) (lixisenatide 20 microgram / 0.2 mL) injection [1 x 3 mL pen device], 1 pack (containered trade product pack) | Is a | containered trade product pack | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR